Klinikum Ernst von Bergmann; Frauenklinik

Potsdam 14467

0 studies enrolling now · 2 studies all time

What they study most

Fatigue, Locally Advanced or Metastatic Breast Cancer, Triple-Negative Breast Cancer

Studies at this site

• To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer — Withdrawn before enrolling
• A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) — Completed